Diagnosis of polyomavirus infection, replication, and disease

Lennette's Laboratory Diagnosis of Viral Infections, Fourth Edition

Volumn , Issue , 2016, Pages 401-424

  Cinque, Paola ^a   Dumoulin, Alexis ^b   Hirsch, Hans H ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

POLYOMAVIRUS;

DIAGNOSIS;

EID: 85052178863     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (136)

1. Cole CN, Polyomavirinae: The Viruses and Their Replication, in Fundamental Virology, DMK Bernard N. Fields, Peter M. Howley, Editor. 1996, Lippincott-Raven Publishers. p. 917-945.
2. Büchen-Osmond C, International Committee on Taxonomy of Viruses Database (ICTVdB), 2008. www.ncbi.nlm.nih.gov/ICTVdb/.
3. Gardner SD, Field AM, Coleman DV, Hulme B, New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet, 1971. 1(7712): p. 1253-57.
4. Zurhein G, Chou SM, Particles Resembling Papova Viruses in Human Cerebral Demyelinating Disease. Science, 1965. 148: p. 1477-9.
5. Padgett BL, Walker DL, ZuRhein GM, et al., Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet, 1971. 1(7712): p. 1257-60.
6. Kleinschmidt-DeMasters BK, TylerKL, Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med, 2005. 353(4): p. 369-74.
7. Langer-Gould A, Atlas SW, Green AJ, et al., Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med, 2005. 353(4): p. 375-81.
8. Van Assche G, Van Ranst M, Sciot R, et al., Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med, 2005. 353(4): p. 362-8.
9. Arthur RR, Shah KV, Baust SJ, et al., Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med, 1986. 315(4): p. 230-234.
10. Apperley JF, Rice SJ, Bishop JA, et al., Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation, 1987. 43(1): p. 108-12.
11. Bedi A, Miller CB, Hanson JL, et al., Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol, 1995. 13(5): p. 1103-1109.
12. Binet I, Nickeleit V, Hirsch HH, et al., Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation, 1999. 67(6): p. 918-922.
13. Nickeleit V, Klimkait T, Binet IF, et al., Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med, 2000. 342(18): p. 1309-15.
14. Hirsch HH, KnowlesW, Dickenmann M, et al., Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med, 2002. 347(7): p. 488-496.
15. Hirsch HH, Steiger J, Polyomavirus BK. Lancet Infect Dis, 2003. 3(10): p. 611-623.
16. Randhawa PS, Finkelstein S, Scantlebury V, et al., Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation, 1999. 67(1): p. 103-109.
17. Hix JK, Braun WE, Isada CM, Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid. Transplantation, 2004. 78(9): p. 1407-1408.
18. Kazory A, Ducloux D, Chalopin JM, et al., The first case of JC virus allograft nephropathy. Transplantation, 2003 76(11): p. 1653-1655.
19. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al., Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation, 2007. 84(3): p. 323-30.
20. Allander T, Andreasson K, Gupta S, et al., Identification of a third human polyomavirus. J Virol, 2007. 81(8): p. 4130-6.
21. Gaynor AM, Nissen MD, Whiley DM, et al., Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog, 2007. 3(5): p. e64.
22. Feng H, Shuda M, Chang Y, Moore PS, Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science, 2008. 319(5866): p. 1096-100.
23. Becker JC, Houben R, Ugurel S, et al., MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol, 2009. 129(1): p. 248-50.
24. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, et al., Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol, 2001. 75(21): p. 10290-9.
25. Luo C, Bueno M, Kant J, Randhawa P, Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories. J Med Virol, 2008. 80(10): p. 1850-7.
26. Luo C, Bueno M, Kant J, et al., Genotyping Schemes for Polyomavirus BK using Gene Specific Phylogenetic Trees and SNP Analysis. J Virol, 2008. 24: p. 24.
27. Dugan AS, Eash S, Atwood WJ, Update on BK virus entry and intracellular trafficking. Transpl Infect Dis, 2006. 8(2): p. 62-7.
28. Low JA, Magnuson B, Tsai B, ImperialeMJ, Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol, 2006. 80(3): p. 1361-6.
29. BernhoffE, Gutteberg TJ, Sandvik K, et al., Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression. Am J Transplant, 2008. 8: p. 1413-1422.
30. Seemayer CA, Seemayer NH, DurmullerU, et al., BK virus large T and VP-1 expression in infected human renal allografts. Nephrol Dial Transplant, 2008. 23(12): p. 3752-61.
31. Hanssen Rinaldo C, Hansen H, Traavik T, Human endothelial cells allow passage of an archetypal BK virus (BKV) strain-a tool for cultivation and functional studies of natural BKV strains. Arch Virol, 2005. 150(7): p. 1449-58.
32. Loeber G, Dorries K, DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol, 1988 62(5): p. 1730-5.
33. Gosert R, Rinaldo CH, Funk GA, et al., Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med, 2008. 205(4): p. 841-52.
34. Rinaldo CH, Myhre MR, Alstad H, et al., Human polyomavirus BK (BKV) transiently transforms and persistently infects cultured osteosarcoma cells. Virus Res, 2003. 93(2): p. 181-7.
35. Hirsch HH, BK virus: opportunity makes a pathogen. Clin Infect Dis, 2005. 41(3): p. 354-60.
36. KnowlesWA, Pipkin P, Andrews N, et al., Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol, 2003. 71(1): p. 115-23.
37. Egli A, Infanti L, Dumoulin A, et al., Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors. J Infect Dis, 2009. 199: p. 837-46.
38. Kean JM, Rao S, Wang M, Garcea RL, Seroepidemiology of human polyomaviruses. PLoS Pathog, 2009. 5(3): p. e1000363.
39. Vanchiere JA, White ZS, Butel JS, Detection of BK virus and simian virus 40 in the urine of healthy children. J Med Virol, 2005. 75(3): p. 447-54.
40. Hirsch HH, Brennan DC, Drachenberg CB, et al., Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation, 2005. 79(10): p. 1277-1286.
41. Noss G, Human polyoma virus type BK infection and T antibody response in renal transplant recipients. Zentralbl Bakteriol Mikrobiol Hyg [A], 1987. 266(3-4): p. 567-74.
42. Wong AS, Chan KH, Cheng VC, et al., Relationship of Pretransplantation Polyoma BK Virus Serologic Findings and BK Viral Reactivation after Hematopoietic Stem Cell Transplantation. Clin Infect Dis, 2007. 44(6): p. 830-7.
43. Hamilton RS, Gravell M, Major EO, Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol, 2000. 38(1): p. 105-9.
44. Randhawa PS, Gupta G, Vats A, et al., Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol, 2006. 13(9): p. 1057-63.
45. Bodaghi S, Comoli, P., Boesch, R., Azzi, A., Gosert, R., Leuenberger, D., Ginevri, F., Hirsch, H.H., Antibody Responses to Recombinant Polyomavirus BK Large T and VP1 Proteins in Pediatric Kidney Transplant Patients. J Clin Micro, 2009. (in press).
46. Bohl DL, Storch GA, Ryschkewitsch C, et al., Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant, 2005. 5(9): p. 2213-21.
47. Ginevri F, De Santis R, Comoli P, et al., Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation, 2003. 75(8): p. 1266-1270.
48. Smith JM, McDonald RA, Finn LS, et al., Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant, 2004. 4(12): p. 2109-17.
49. Bohl DL, Brennan DC, Ryschkewitsch C, et al., BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol, 2008. 43(2): p. 184-9.
50. Randhawa P, Bohl D, Brennan D, et al., Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol, 2008. 15(10): p. 1564-71.
51. Leuenberger D, Andresen PA, Gosert R, et al., Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clinical and Vaccine Immunology, 2007. 14(8): p. 959-68.
52. Rinaldo CH, Traavik T, Hey A, The agnogene of the human polyomavirus BK is expressed. J Virol, 1998. 72(7): p. 6233-6.
53. Comoli P, Binggeli S, Ginevri F, Hirsch HH, Polyomavirus-associated nephropathy: update on BK virusspecific immunity. Transpl Infect Dis, 2006. 8(2): p. 86-94.
54. Comoli P, Hirsch HH, Ginevri F, Cellular immune responses to BK virus. Curr Opin Organ Transplant, 2008 13 (6): p. 569-74.
55. Binggeli S, Egli A, Schaub S, et al., Polyomavirus BK-Specific Cellular Immune Response to VP1 and Large T-Antigen in Kidney Transplant Recipients. Am J Transplant, 2007. 7(5): p. 1131-9.
56. Comoli P, Basso S, Azzi A, et al., Dendritic cells pulsed with polyomavirusBK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol, 2003. 14(12): p. 3197-3204.
57. Chen Y, Trofe J, Gordon J, et al., BKV and JCV large T antigen-specific CD8(+) T cell response in HLA A*0201(+) kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol, 2008. 42(2): p. 198-202.
58. Ginevri F, Azzi A, Hirsch HH, et al., Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant, 2007. 7(12): p. 2727-35.
59. Egli A, Koehli, S., Dickenmann, M., Hirsch, H.H., Inhibition of Polyomavirus BK-and Cytomegalovirusspecific T-cell responses by immunosuppressive drugs. Transplantation, 2009. in press.
60. Purighalla R, Shapiro R, McCauley J, Randhawa P, BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis, 1995. 26(4): p. 671-3.
61. Nickeleit V, Hirsch HH, Binet IF, et al., Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol, 1999. 10(5): p. 1080-1089.
62. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al., Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant, 2004. 4(12): p. 2082-92.
63. Jorgensen GE, Hammarin AL, Bratt G, et al., Identification of a unique BK virus variant in the CNS of a patient with AIDS. J Med Virol, 2003. 70(1): p. 14-9.
64. Drachenberg CB, Beskow CO, Cangro CB, et al., Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol, 1999. 30(8): p. 970-7.
65. Singh HK, Bubendorf L, MihatschMJ, et al., Urine cytology findings of polyomavirus infections. Adv Exp Med Biol, 2006. 577: p. 201-12.
66. Singh HK, Andreoni KA, Madden V, et al., Presence of urinary haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol, 2009. 20(2): p. 416-27.
67. Viscount HB, Eid AJ, Espy MJ, et al., Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation, 2007. 84(3): p. 340-5.
68. Gordon J, Brennan D., Limaye, A., Randhawa, P., Storch, G., Trofe, J., Weck, K., and Hirsch, H.H., Multicenter validation of polyomavirus BK quantification for screening and monitoring of renal transplant recipients. Am J Transplant, 2005. 5(Suppl. 11): p. S381-S382.
69. Hoffman NG, Cook L, Atienza EE, et al., Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol, 2008. 46(8): p. 2671-80.
70. MacKayW, Paola C, HirschH, et al., Nucleic acid tests for JCV and BKV in the management of immunocompromised patients: results of an international external quality assessment study Quality Control forMolecular Diagnostics (QCMD) (Abstract P5-03). ESCV 2008-Clinical Virology Annual Meeting, Saarisklä, Finnland, 2008: p. 39.
71. Hirsch HH, MohauptM, Klimkait T, Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis, 2001. 184(11): p. 1494-5; author reply 1495-6.
72. Wu SW, Chang HR, Hsieh MC, et al., Early diagnosis of polyomavirus type BK infection in tailoring immunosuppression for kidney transplant patients: screening with urine qualitative polymerase chain reaction assay. Transplant Proc, 2008. 40(7): p. 2389-91.
73. Almeras C, Foulongne V, Garrigue V, et al., Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation, 2008 85 (8): p. 1099-104.
74. Giraldi C, Noto A, Tenuta R, et al., Prospective study of BKV nephropathy in 117 renal transplant recipients. New Microbiol, 2007. 30(2): p. 127-30.
75. Ding R, Suthanthiran M, Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. Transplantation, 2003. 76(2): p. 446.
76. Dropulic LK, Jones RJ, Polyomavirus BK infection in blood andmarrow transplant recipients. Bone Marrow Transplant, 2008. 41(1): p. 11-8.
77. Khanna N, Wolbers, M., Mueller, N.J., Garzoni, C., DuPasquier, R.A., Fux, C.A., Vernazza, P., Bernasconi, E., Viscidi, R., Battegay, M., Hirsch, H.H., JCV-Specific Immune Responses in HIV-1 Patients with Progressive Multifocal Leukoencephalopathy. J Virol, 2009. [Epub ahead of print].
78. Weber T, Trebst C, Frye S, et al., Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis, 1997. 176(1): p. 250-4.
79. Giudici B, Vaz B, Bossolasco S, et al., Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis, 2000. 30(1): p. 95-9.
80. Du Pasquier RA, Kuroda MJ, Zheng Y, et al., A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain, 2004. 127(Pt 9): p. 1970-8.
81. Du Pasquier RA, Clark KW, Smith PS, et al., JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol, 2001. 7(4): p. 318-22.
82. Koralnik IJ, Du Pasquier RA, Kuroda MJ, et al., Association of prolonged survival in HLA-A2+progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol, 2002. 168(1): p. 499-504.
83. Du Pasquier RA, Autissier P, Zheng Y, et al., Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. Aids, 2005. 19(18): p. 2069-76.
84. Sabath BF, Major EO, Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis, 2002. 186 Suppl 2: p. S180-6.
85. Sweet TM, Del Valle L, Khalili K, Molecular biology and immunoregulation of human neurotropic JC virus in CNS. J Cell Physiol, 2002. 191(3): p. 249-56.
86. Cinque P, Scarpellini P, Vago L, et al., Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. Aids, 1997. 11(1): p. 1-17.
87. Hirsch HH, Meylan PR, ZimmerliW, et al., HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus. Clin Microbiol Infect, 1998. 4(10): p. 577-584.
88. Antinori A, Cingolani A, Lorenzini P, et al., Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol, 2003. 9 Suppl 1: p. 47-53.
89. Marzocchetti A, Di Giambenedetto S, Cingolani A, et al., Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol, 2005. 43(8): p. 4175-7.
90. Yiannoutsos CT, Major EO, Curfman B, et al., Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol, 1999. 45(6): p. 816-21.
91. Bossolasco S, Calori G, Moretti F, et al., Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis, 2005. 40(5): p. 738-44.
92. De Luca A, Pezzotti, P., Gasnault, J., Cinque, P., Berenguer, J., Di Giambenedetto, S., Cingolani, A., Taofik, Y., Pedale, R., Miralles, P., Larussa, D., Sinha, S., Cauda, R., Marra, C. M., Ammassari, A., and Antinori, A., Survival and neurological outcome with or without cidofovir (CDV) in AIDS-related progressive multifocal leukoencephalopathy (PML) on HAART: A multicohort analysis. J Neurovirol, 2005. 11 ((S2)): p. S16-S124.
93. Khanna N, Elzi, L., Mueller, N.J., Garzoni, C., Cavassini, M., Fux, C.A., Vernazza, P., Bernasconi, E., Battegay, M., Hirsch, H.H., for the Swiss HIV Cohort Study, Incidence and Outcome of Progressive Multifocal Leukoencephalopathy in 20 years of the Swiss HIV Cohort Study. Clinical Infectious Diseases, 2009 48 p. 1459-66.
94. Sharp CP, Norja P, Anthony I, et al., Reactivation and Mutation of Newly Discovered WU, KI, and Merkel Cell Carcinoma Polyomaviruses in Immunosuppressed Individuals. J Infect Dis, 2009. 199(3): p. 398-404.
95. Knowles WA, Pillay D, Johnson MA, et al., Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol, 1999. 59(4): p. 474-479.
96. Koralnik IJ, Boden D, Mai VX, et al., JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology, 1999. 52(2): p. 253-60.
97. Lednicky JA, Vilchez RA, Keitel WA, et al., Polyomavirus JCV excretion and genotype analysis in HIVinfected patients receiving highly active antiretroviral therapy. Aids, 2003. 17(6): p. 801-7.
98. Markowitz RB, Thompson HC, Mueller JF, et al., Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis, 1993. 167(1): p. 13-20.
99. Sundsfjord A, Flaegstad T, Flo R, et al., BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis, 1994. 169(3): p. 485-490.
100. Behzad-Behbahani A, Klapper PE, Vallely PJ, et al., Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol, 2004. 29(4): p. 224-229.
101. Shah KV, Daniel RW, Strickler HD, Goedert JJ, Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis, 1997. 176(6): p. 1618-21.
102. Grinnell BW, Martin JD, Padgett BL, Walker DL, Naturally occurring and passage-induced variation in the genome of JC virus. Prog Clin Biol Res, 1983. 105: p. 61-77.
103. Caldarelli-Stefano R, Vago L, Omodeo-Zorini E, et al., Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals. J Neurovirol, 1999. 5(2): p. 125-33.
104. Newman JT, Frisque RJ, Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient. J Med Virol, 1997. 52(3): p. 243-52.
105. Koralnik IJ, Wuthrich C, Dang X, et al., JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol, 2005. 57(4): p. 576-80.
106. Richardson EP, Jr., Progressive multifocal leukoencephalopathy. N Engl J Med, 1961. 265: p. 815-23.
107. Du Pasquier RA, Corey S, Margolin DH, et al., Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology, 2003. 61(6): p. 775-82.
108. Cinque P, Koralnik IJ, Clifford DB, The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol, 2003. 9 Suppl 1: p. 88-92.
109. Bialasiewicz S, Whiley DM, Lambert SB, et al., A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children. J Clin Virol, 2007. 40(1): p. 15-8.
110. Bialasiewicz S, Whiley DM, Lambert SB, et al., Development and evaluation of real-time PCR assays for the detection of the newly identified KI and WU polyomaviruses. J Clin Virol, 2007. 40(1): p. 9-14.
111. Ridd K, Yu S, Bastian BC, The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol, 2009. 129(1): p. 250-2.
112. Bluemn EG, Paulson KG, Higgins EE, et al., Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls. J Clin Virol, 2009. 5: p. 5.
113. Dang X, Axthelm MK, Letvin NL, Koralnik IJ, Rearrangement of simian virus 40 regulatory region is not required for induction of progressive multifocal leukoencephalopathy in immunosuppressed rhesus monkeys. J Virol, 2005. 79(3): p. 1361-6.
114. Axthelm MK, Koralnik IJ, Dang X, et al., Meningoencephalitis and demyelination are pathologic manifestations of primary polyomavirus infection in immunosuppressed rhesus monkeys. J Neuropathol Exp Neurol, 2004 63 (7): p. 750-8.
115. Strickler HD, Goedert JJ, Devesa SS, et al., Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst, 2003. 95(1): p. 38-45.
116. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M, Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet, 2004. 364(9440): p. 1157-66.
117. Rivera Z, Strianese O, Bertino P, et al., The relationship between simian virus 40 and mesothelioma. Curr Opin Pulm Med, 2008. 14(4): p. 316-21.
118. Patel NC, Vilchez RA, Killen DE, et al., Detection of polyomavirus SV40 in tonsils from immunocompetent children. J Clin Virol, 2008. 43(1): p. 66-72.
119. Pancaldi C, Balatti V, Guaschino R, et al., Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect, 2008.
120. Vanchiere JA, Nicome RK, Greer JM, et al., Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis, 2005. 192(4): p. 658-64.
121. Thomas LD, Vilchez RA, White ZS, et al., A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis, 2007. 195(3): p. 442-9.
122. Li RM, Branton MH, Tanawattanacharoen S, et al., Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol, 2002. 13(9): p. 2320-30.
123. Li RM, Mannon RB, Kleiner D, et al., BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation, 2002. 74(11): p. 1497-504.
124. Chhajed PN, Bubendorf L, HirschH, et al., Mesothelioma after lung transplantation. Thorax, 2006. 61(10): p. 916-7.
125. Bergsagel DJ, Finegold MJ, Butel JS, et al., DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med, 1992. 326(15): p. 988-93.
126. Weber T, Klapper PE, Cleator GM, et al., Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis. J Virol Methods, 1997. 69(1-2): p. 231-7.
127. Drews K, Bashir T, Dorries K, Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR. J Virol Methods, 2000. 84(1): p. 23-36.
128. Biel SS, Held TK, Landt O, et al., Rapid quantification and differentiation of human polyomavirus DNA in undiluted urine from patients after bone marrow transplantation. J Clin Microbiol, 2000. 38(10): p. 3689-95.
129. Limaye AP, Jerome KR, Kuhr CS, et al., Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis, 2001. 183(11): p. 1669-72.
130. Herman J, Van Ranst M, Snoeck R, et al., Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transplant, 2004. 8(5): p. 485-92.
131. Beck RC, Kohn DJ, Tuohy MJ, et al., Detection of polyoma virus in brain tissue of patients with progressive multifocal leukoencephalopathy by real-time PCR and pyrosequencing. Diagn Mol Pathol, 2004. 13(1): p. 15-21.
132. McNees AL, White ZS, Zanwar P, et al., Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol, 2005. 34(1): p. 52-62.
133. Sehbani L, Kabamba-Mukadi B, Vandenbroucke AT, et al., Specific and quantitative detection of human polyomaviruses BKV and JCV by LightCycler real-time PCR. J Clin Virol, 2006. 36(2): p. 159-62.
134. Si-Mohamed A, GoffJL, Desire N, et al., Detection and quantitation of BK virus DNA by real-time polymerase chain reaction in the LT-ag gene in adult renal transplant recipients. J Virol Methods, 2006. 131(1): p. 21-27.
135. Fink MC, Penalva de Oliveira AC, Milagres FA, et al., JC virus DNA in cerebrospinal fluid samples from Brazilian AIDS patients with focal brain lesions without mass effect. J Infect, 2006. 52(1): p. 30-6.
136. Marzocchetti A, Sanguinetti M, Giambenedetto SD, et al., Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis. J Neurovirol, 2007. 13(4): p. 338-46.